1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wakelee H, Kelly K and Edelman MJ: 50
Years of progress in the systemic therapy of non-small cell lung
cancer. Am Soc Clin Oncol Educ Book. pp. 177–189. 2014, View Article : Google Scholar
|
3
|
Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J
and Zhang HT: MiR-142-3p represses TGF-β-induced growth inhibition
through repression of TGFbetaR1 in non-small cell lung cancer.
FASEB J. 28:2696–2704. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Grutsch JF, Wood PA, Du-Quiton J, Reynolds
JL, Lis CG, Levin RD, Ann Daehler M, Gupta D, Quiton DF and
Hrushesky WJ: Validation of actigraphy to assess circadian
organization and sleep quality in patients with advanced lung
cancer. J Circadian Rhythms. 9:42011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kleisiaris CF, Kritsotakis EI, Daniil Z,
Tzanakis N, Papaioannou A and Gourgoulianis KI: The prevalence of
obstructive sleep apnea-hypopnea syndrome-related symptoms and
their relation to airflow limitation in an elderly population
receiving home care. Int J Chron Obstruct Pulmon Dis. 9:1111–1117.
2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bouloukaki I, Papadimitriou V, Sofras F,
Mermigkis C, Moniaki V, Siafakas NM and Schiza SE: Abnormal
cytokine profile in patients with obstructive sleep apnea-hypopnea
syndrome and erectile dysfunction. Mediators Inflamm.
2014:5689512014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yang J, Qin G, Luo M, Chen J, Zhang Q, Li
L, Pan L and Qin S: Reciprocal positive regulation between Cx26 and
PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC
cells via GJIC-independent induction of EMT. Cell Death Dis.
6:e18292015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Crespin S, Bacchetta M, Bou Saab J,
Tantilipikorn P, Bellec J, Dudez T, Nguyen TH, Kwak BR, Lacroix JS,
Huang S, et al: Cx26 regulates proliferation of repairing basal
airway epithelial cells. Int J Biochem Cell Biol. 52:152–160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Garcia IE, Maripillán J, Jara O, Ceriani
R, Palacios-Munoz A, Ramachandran J, Olivero P, Perez-Acle T,
González C, Sáez JC, et al: Keratitis-ichthyosis-deafness
syndrome-associated Cx26 mutants produce nonfunctional gap
junctions but hyperactive hemichannels when co-expressed with wild
type Cx43. J Invest Dermatol. 135:1338–1347. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sulkowska U, Febp AW and Sulkowski S:
Association of STAT3 with Cx26 and Cx43 in human uterine
endometrioid adenocarcinoma. Oncol Lett. 11:4134–4138. 2016.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Deben C, Wouters A, Op de Beeck K, van Den
Bossche J, Jacobs J, Zwaenepoel K, Peeters M, Van Meerbeeck J,
Lardon F, Rolfo C, et al: The MDM2-inhibitor Nutlin-3 synergizes
with cisplatin to induce p53 dependent tumor cell apoptosis in
non-small cell lung cancer. Oncotarget. 6:22666–22679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Chang H, Li C, Huo K, Wang Q, Lu L, Zhang
Q, Wang Y and Wang W: Luteolin prevents H2O2-induced apoptosis in
H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway.
Biomed Res Int. 2016:51258362016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Reddy R, Buckley S, Doerken M, Barsky L,
Weinberg K, Anderson KD, Warburton D and Driscoll B: Isolation of a
putative progenitor subpopulation of alveolar epithelial type 2
cells. Am J Physiol Lung Cell Mol Physiol. 286:L658–L667. 2004.
View Article : Google Scholar
|
14
|
Bao B, Groves K, Zhang J, Handy E, Kennedy
P, Cuneo G, Supuran CT, Yared W, Rajopadhye M and Peterson JD: In
vivo imaging and quantification of carbonic anhydrase IX expression
as an endogenous biomarker of tumor hypoxia. PLoS One.
7:e508602012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tang D, Yan T, Zhang J, Jiang X, Zhang D
and Huang Y: Notch1 signaling contributes to hypoxia-induced high
expression of Integrin β1 in keratinocyte migration. Sci Rep.
7:439262017. View Article : Google Scholar
|
16
|
Hau S, Reich DM, Scholz M, Naumann W,
Emmrich F, Kamprad M and Boltze J: Evidence for neuroprotective
properties of human umbilical cord blood cells after neuronal
hypoxia in vitro. BMC Neurosci. 9:302008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Bouley R, Lin HY, Raychowdhury MK,
Marshansky V, Brown D and Ausiello DA: Downregulation of the
vasopressin type 2 receptor after vasopressin-induced
internalization: Involvement of a lysosomal degradation pathway. Am
J Physiol Cell Physiol. 288:C1390–C1401. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kim SJ, Kim MY, Lee EJ, Ahn YS and Baik
JH: Distinct regulation of internalization and mitogen-activated
protein kinase activation by two isoforms of the dopamine D2
receptor. Mol Endocrinol. 18:640–652. 2004. View Article : Google Scholar
|
19
|
Atkins D, Reiffen KA, Tegtmeier CL,
Winther H, Bonato MS and Storkel S: Immunohistochemical detection
of EGFR in paraffin-embedded tumor tissues: Variation in staining
intensity due to choice of fixative and storage time of tissue
sections. J Histochem Cytochem. 52:893–901. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
21
|
Wilmanns C, Fan D, O'Brian CA, Bucana CD
and Fidler IJ: Orthotopic and ectopic organ environments
differentially influence the sensitivity of murine colon carcinoma
cells to doxorubicin and 5-fluorouracil. Int J Cancer. 52:98–104.
1992. View Article : Google Scholar : PubMed/NCBI
|
22
|
Schlagbauer-Wadl H, Griffioen M, van Elsas
A, Schrier PI, Pustelnik T, Eichler HG, Wolff K, Pehamberger H and
Jansen B: Influence of increased c-Myc expression on the growth
characteristics of human melanoma. J Invest Dermatol. 112:332–336.
1999. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hong QY, Wu GM, Qian GS, Hu CP, Zhou JY,
Chen LA, Li WM, Li SY, Wang K, Wang Q, et al: Prevention and
management of lung cancer in China. Cancer. 121(Suppl 17):
S3080–S3088. 2015. View Article : Google Scholar
|
24
|
Long F, Su JH, Liang B, Su LL and Jiang
SJ: Identification of gene biomarkers for distinguishing small-cell
lung cancer from non-small-cell lung cancer using a network-based
approach. Biomed Res Int. 2015:6853032015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Olmeda B, Umstead TM, Silveyra P, Pascual
A, Lopez-Barneo J, Phelps DS, Floros J and Perez-Gil J: Effect of
hypoxia on lung gene expression and proteomic profile: Insights
into the pulmonary surfactant response. J Proteomics. 101:179–191.
2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Teleki I, Szasz AM, Maros ME, Gyorffy B,
Kulka J, Meggyeshazi N, Kiszner G, Balla P, Samu A and Krenacs T:
Correlations of differentially expressed gap junction connexins
Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and
prognosis. PLoS One. 9:e1125412014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Losa D, Chanson M and Crespin S: Connexins
as therapeutic targets in lung disease. Expert Opin Ther Targets.
15:989–1002. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Liu T, Li Y, Zhang B, Ma L, Liu W, Li Z
and Jin F: The role of phosphorylated Cx43 on PKC mediated Ser368
in lung injury induced by seawater inhalation. Inflammation.
38:1847–1854. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lin J, Huang H, Lv G, Xu X, Lin W, Xu X,
Cheng J and Zheng M: Chronic prenatal hypoxia impairs cochlear
development, a mechanism involving connexin26 expression and
promoter methylation. Int J Mol Med. 41:852–858. 2018.
|
30
|
Wu X, Huang W, Luo G and Alain LA: Hypoxia
induces connexin 43 dysregulation by modulating matrix
metalloproteinases via MAPK signaling. Mol Cell Biochem.
384:155–162. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Otto T, Gellhaus A, Lüschen N, Scheidler
J, Bendix I, Dunk C, Wolf N, Lennartz K, Koninger A, Schmidt M, et
al: Oxygen sensitivity of placental trophoblast Connexins 43 and
46: A role in preeclampsia? J Cell Biochem. 116:2924–2937. 2015.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Morrow JK, Lin HK, Sun SC and Zhang S:
Targeting ubiquitination for cancer therapies. Future Med Chem.
7:2333–2350. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Falk MM, Kells RM and Berthoud VM:
Degradation of connexins and gap junctions. FEBS Lett.
588:1221–1229. 2014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zhao JQ, Sun FJ, Liu SS, Yang J, Wu YQ, Li
GS, Chen QY and Wang JX: Expression of connexin 43 and E-cadherin
protein and mRNA in non-small cell lung cancers in Chinese
patients. Asian Pac J Cancer Prev. 14:639–643. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS and Wu CW:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wang W and Hu Y: Small molecule agents
targeting the p53-MDM2 pathway for cancer therapy. Med Res Rev.
32:1159–1196. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zhang P, Kratz AS, Salama M, Elabd S,
Heinrich T, Wittbrodt J, Blattner C and Davidson G: Expression
screening using a Medaka cDNA library identifies evolutionarily
conserved regulators of the p53/Mdm2 pathway. BMC Biotechnol.
15:922015. View Article : Google Scholar : PubMed/NCBI
|